Pieber, TR; Famulla, S; Eilbracht, J; Cescutti, J; Soleymanlou, N;
Johansen, O; Woerle, HJ; Broedl, UC; Kaspers, S.
Empagliflozin reduces HbA1c with lower insulin doses in patients
with type 1 diabetes: a 4-week placebo-controlled trial (EASE-1).
Diabetologia. 2015; 58(Suppl 1):S91-S91.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN.
[Oral Communication]
Web of Science